Technology Assessment, Biomedical
"Technology Assessment, Biomedical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
| Descriptor ID |
D013673
|
| MeSH Number(s) |
N03.880 N05.715.360.825
|
| Concept/Terms |
Technology Assessment, Biomedical- Technology Assessment, Biomedical
- Biomedical Technology Assessment
- Technology Assessment, Health
- Assessment, Health Technology
- Assessments, Health Technology
- Health Technology Assessment
- Health Technology Assessments
- Technology Assessments, Health
- Assessment, Biomedical Technology
- Assessments, Biomedical Technology
- Biomedical Technology Assessments
- Technology Assessments, Biomedical
Technology Assessment- Technology Assessment
- Assessment, Technology
- Assessments, Technology
- Technology Assessments
|
Below are MeSH descriptors whose meaning is more general than "Technology Assessment, Biomedical".
Below are MeSH descriptors whose meaning is more specific than "Technology Assessment, Biomedical".
This graph shows the total number of publications written about "Technology Assessment, Biomedical" by people in this website by year, and whether "Technology Assessment, Biomedical" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 1 | 2 |
| 1996 | 4 | 1 | 5 |
| 1997 | 1 | 1 | 2 |
| 1998 | 5 | 2 | 7 |
| 1999 | 8 | 1 | 9 |
| 2000 | 2 | 3 | 5 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 3 | 6 |
| 2004 | 1 | 3 | 4 |
| 2005 | 3 | 4 | 7 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 4 | 5 |
| 2008 | 5 | 10 | 15 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 3 | 4 |
| 2011 | 4 | 3 | 7 |
| 2012 | 3 | 2 | 5 |
| 2013 | 2 | 3 | 5 |
| 2014 | 2 | 2 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 2 | 4 | 6 |
| 2017 | 5 | 4 | 9 |
| 2018 | 5 | 6 | 11 |
| 2019 | 9 | 2 | 11 |
| 2020 | 7 | 5 | 12 |
| 2021 | 5 | 4 | 9 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 3 | 3 | 6 |
Below are the most recent publications written about "Technology Assessment, Biomedical" by people in Profiles.
-
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation. Health Technol Assess. 2024 08; 28(38):1-237.
-
Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch. Value Health. 2024 Nov; 27(11):1507-1514.
-
Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis. Lancet Oncol. 2024 Aug; 25(8):979-988.
-
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices. Forum Health Econ Policy. 2024 Jun 01; 27(1):29-116.
-
Can Generalized Cost-Effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation? Value Health. 2024 Aug; 27(8):1100-1107.
-
Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results. Pharmacoeconomics. 2024 Jul; 42(7):783-795.
-
The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum. J Manag Care Spec Pharm. 2023 09; 29(9):1078-1083.
-
The effectiveness and value of gene therapy for hemophilia: A Summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum. J Manag Care Spec Pharm. 2023 May; 29(5):576-581.
-
Assessments of the Value of New Interventions Should Include Health Equity Impact. Pharmacoeconomics. 2022 05; 40(5):489-495.
-
Adjustable Sutures in the Treatment of Strabismus: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022 01; 129(1):100-109.